Ting Yin
Research Subjects
Ting Yin has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Jiuquan Zhang
Department of Radiology, Chongqing University Cancer Hospital, School of Medicine Chongqing University Chongqing China
3 shared publications - Yao Huang
Department of Radiology Chongqing University Cancer Hospital, Chongqing Key Laboratory for Intelligent Oncology in Breast Cancer (iCQBC) Chongqing China
3 shared publications - Ying Cao
School of Medicine, Chongqing University, Chongqing, China
3 shared publications - Dan Wu
Key Laboratory for Biomedical Engineering of Ministry of Education, Department of Biomedical Engineering, College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou 310027, China
2 shared publications - Huifang Chen
Department of Radiology, Chongqing University Cancer Hospital, Chongqing Key Laboratory for Intelligent Oncology in Breast Cancer, No. 181 Hanyu Rd, Shapingba District, Chongqing 400030, China
2 shared publications - Xiaoxia Wang
Department of Radiology, Chongqing University Cancer Hospital, Chongqing Key Laboratory for Intelligent Oncology in Breast Cancer, No. 181 Hanyu Rd, Shapingba District, Chongqing 400030, China
2 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by MIT Press in Imaging Neuroscience
- Vol. 4
SRNR: Deep learning-based MRI super-resolution using noisy high-resolution reference data
Deep learning-based super-resolution (SR) techniques offer a powerful tool to enhance the spatial resolution of magnetic resonance imaging (MRI) without increasing scan time. However, most supervised SR methods rely on high-resolution, high-signal-to-noise ratio (SNR) reference data for training, which are difficult to acquire in many clinical settings, such as in time-constrained pediatric imaging. Inspired by the Noise2Noise principle, we propose SRNR, a new training paradigm that enables supervised SR using noisy high-resolution images as references. SRNR was systematically evaluated on both pediatric and adult simulated data across different noise levels of the reference data. SRNR generated super-resolved image volumes with high similarity to the high-resolution references (PSNR: 32.5–35.2 dB) and improved downstream image analysis performance, including tissue segmentation (white matter Dice coefficient: 0.951–0.960) and cortical surface reconstruction (cortical thickness absolute difference: 0.200–0.255 mm). Furthermore, SRNR was shown to be effective on clinically acquired pediatric brain MRI data, achieving improvements consistent with those observed in the simulated experiments. These results demonstrate that SRNR substantially reduces reliance on clean, high-SNR training data and enables effective SR under clinically realistic acquisition constraints, thereby improving the feasibility of deploying deep learning-based SR in pediatric MRI and related applications.
- 3 November 2026
- Published by MIT Press in Imaging Neuroscience
- Vol. 4
Open AccessSRNR: Deep learning-based MRI super-resolution using noisy high-resolution reference data
Deep learning-based super-resolution (SR) techniques offer a powerful tool to enhance the spatial resolution of magnetic resonance imaging (MRI) without increasing scan time. However, most supervised SR methods rely on high-resolution, high-signal-to-noise ratio (SNR) reference data for training, which are difficult to acquire in many clinical settings, such as in time-constrained pediatric imaging. Inspired by the Noise2Noise principle, we propose SRNR, a new training paradigm that enables supervised SR using noisy high-resolution images as references. SRNR was systematically evaluated on both pediatric and adult simulated data across different noise levels of the reference data. SRNR generated super-resolved image volumes with high similarity to the high-resolution references (PSNR: 32.5–35.2 dB) and improved downstream image analysis performance, including tissue segmentation (white matter Dice coefficient: 0.951–0.960) and cortical surface reconstruction (cortical thickness absolute difference: 0.200–0.255 mm). Furthermore, SRNR was shown to be effective on clinically acquired pediatric brain MRI data, achieving improvements consistent with those observed in the simulated experiments. These results demonstrate that SRNR substantially reduces reliance on clean, high-SNR training data and enables effective SR under clinically realistic acquisition constraints, thereby improving the feasibility of deploying deep learning-based SR in pediatric MRI and related applications.
- Open Access
- 17 June 2026
- Published by Taylor & Francis in Annals of Medicine
- Vol. 58 (1) , 2687212
Navigating the diagnostic ‘gray zone’: prospective evaluation of an integrated MRI-Biomarker model for renal allograft triage
A critical dilemma in post-transplant surveillance is determining when minor functional changes (subtle serum creatinine fluctuations or slow renal function decline) or ambiguous ultrasound findings (including mildly elevated resistive index or cortical echogenicity) warrant invasive biopsy and treatment modification. We aimed to develop a non-invasive integrated tool combining advanced diffusion MRI with functional biomarkers to stratify patients within this diagnostic gray zone. In this prospective study, 120 renal transplant recipients underwent multi-b-value diffusion-weighted imaging at 3.0 T within 48 h prior to an allograft biopsy. Quantitative parameters of six diffusion MRI models were extracted from renal cortex and medulla. Clinical indicators, including serum HCO3-, were recorded. To establish a clear endpoint, patients were categorized into a Treatment-Changed group (presence of actionable active pathology, requiring modified therapies) and a Treatment-Unchanged group (normal or solely chronic/non-reversible lesions). Multivariable logistic regression identified independent predictors. Diagnostic performance was assessed using area under the curve (AUC) using repeated stratified 5-fold cross validation with 10 repeats and bootstrap resampling. Kaplan–Meier analysis assessed the association between model-based risk and subsequent graft functional decline, defined as a 30% or greater decrease in estimated glomerular filtration rate (eGFR) from baseline. The cortical distributed diffusion coefficient (DDC) and serum HCO3-, emerged as independent predictors of treatment-changed group. The integrated model achieved an AUC of 0.941, significantly outperforming the standard clinical reference model (eGFR, proteinuria, and ultrasound; AUC 0.563). Net reclassification improvement (0.479) demonstrated the model correctly reclassified 45.6% of patients. Furthermore, model-derived high-risk status significantly predicted long-term graft functional decline (log-rank p = 0.005). This integrated multiparametric protocol provides promising preliminary decision support for renal allograft surveillance. By noninvasively identifying the potential presence of actionable active pathology, this preliminary model may help optimize biopsy referrals and stratify patients who potentially require treatment modification. However, given the single-centre design, external validation is required before clinical implementation.
- 17 June 2026
- Published by Taylor & Francis in Annals of Medicine
- Vol. 58 (1) , 2687212
Open AccessNavigating the diagnostic ‘gray zone’: prospective evaluation of an integrated MRI-Biomarker model for renal allograft triage
A critical dilemma in post-transplant surveillance is determining when minor functional changes (subtle serum creatinine fluctuations or slow renal function decline) or ambiguous ultrasound findings (including mildly elevated resistive index or cortical echogenicity) warrant invasive biopsy and treatment modification. We aimed to develop a non-invasive integrated tool combining advanced diffusion MRI with functional biomarkers to stratify patients within this diagnostic gray zone. In this prospective study, 120 renal transplant recipients underwent multi-b-value diffusion-weighted imaging at 3.0 T within 48 h prior to an allograft biopsy. Quantitative parameters of six diffusion MRI models were extracted from renal cortex and medulla. Clinical indicators, including serum HCO3-, were recorded. To establish a clear endpoint, patients were categorized into a Treatment-Changed group (presence of actionable active pathology, requiring modified therapies) and a Treatment-Unchanged group (normal or solely chronic/non-reversible lesions). Multivariable logistic regression identified independent predictors. Diagnostic performance was assessed using area under the curve (AUC) using repeated stratified 5-fold cross validation with 10 repeats and bootstrap resampling. Kaplan–Meier analysis assessed the association between model-based risk and subsequent graft functional decline, defined as a 30% or greater decrease in estimated glomerular filtration rate (eGFR) from baseline. The cortical distributed diffusion coefficient (DDC) and serum HCO3-, emerged as independent predictors of treatment-changed group. The integrated model achieved an AUC of 0.941, significantly outperforming the standard clinical reference model (eGFR, proteinuria, and ultrasound; AUC 0.563). Net reclassification improvement (0.479) demonstrated the model correctly reclassified 45.6% of patients. Furthermore, model-derived high-risk status significantly predicted long-term graft functional decline (log-rank p = 0.005). This integrated multiparametric protocol provides promising preliminary decision support for renal allograft surveillance. By noninvasively identifying the potential presence of actionable active pathology, this preliminary model may help optimize biopsy referrals and stratify patients who potentially require treatment modification. However, given the single-centre design, external validation is required before clinical implementation.
- Open Access
- 21 November 2025
- Published by Elsevier in EBioMedicine
- Vol. 122, 106034
One-stop early noninvasive evaluation of renal allograft rejection and fibrosis: microstructural mapping via time-dependent diffusion MRI
- 21 November 2025
- Published by Elsevier in EBioMedicine
- Vol. 122, 106034
Open AccessOne-stop early noninvasive evaluation of renal allograft rejection and fibrosis: microstructural mapping via time-dependent diffusion MRI
- 1 July 2025
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 316 (1) , e242969
Comparing Multi–b-Value Diffusion MRI Models for Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
A model combining clinicopathologic variables and diffusion kurtosis imaging parameters after two cycles of neoadjuvant chemotherapy demonstrated excellent performance in predicting pathologic complete response in participants with breast cancer.
- 1 July 2025
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 316 (1) , e242969
Comparing Multi–b-Value Diffusion MRI Models for Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
A model combining clinicopathologic variables and diffusion kurtosis imaging parameters after two cycles of neoadjuvant chemotherapy demonstrated excellent performance in predicting pathologic complete response in participants with breast cancer.
- Top Cited Papers
- 1 October 2024
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 313 (1) , e240288
Time-Dependent Diffusion MRI Helps Predict Molecular Subtypes and Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer
Time-dependent diffusion MRI–based microstructural mapping was shown to be an effective method in helping to identify molecular subtypes and predict pathologic complete response to neoadjuvant chemotherapy in participants with breast cancer.
- 1 October 2024
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 313 (1) , e240288
Top Cited PapersTime-Dependent Diffusion MRI Helps Predict Molecular Subtypes and Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer
Time-dependent diffusion MRI–based microstructural mapping was shown to be an effective method in helping to identify molecular subtypes and predict pathologic complete response to neoadjuvant chemotherapy in participants with breast cancer.
- 4 August 2023
- Published by Elsevier in Diagnostic and Interventional Imaging
- Vol. 104 (12) , 605-614
Early prediction of pathologic complete response of breast cancer after neoadjuvant chemotherapy using longitudinal ultrafast dynamic contrast-enhanced MRI
- 4 August 2023
- Published by Elsevier in Diagnostic and Interventional Imaging
- Vol. 104 (12) , 605-614
Early prediction of pathologic complete response of breast cancer after neoadjuvant chemotherapy using longitudinal ultrafast dynamic contrast-enhanced MRI
- 17 October 2022
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 58 (1) , 93-105
Assessment of Prognostic Factors and Molecular Subtypes of Breast Cancer With a Continuous‐Time Random‐Walk MR Diffusion Model: Using Whole Tumor Histogram Analysis
Background: The continuous‐time random‐walk (CTRW) diffusion model to evaluate breast cancer prognosis is rarely reported.Purpose: To investigate the correlations between apparent diffusion coefficient (ADC) and CTRW‐specific parameters with prognostic factors and molecular subtypes of breast cancer.Study Type: Retrospective.Population: One hundred fifty‐seven women (median age, 50 years; range, 26–81 years) with histopathology‐confirmed breast cancer.Field Strength/Sequence: Simultaneous multi‐slice readout‐segmented echo‐planar imaging at 3.0T.Assessment: The histogram metrics of ADC, anomalous diffusion coefficient (D), temporal diffusion heterogeneity (α), and spatial diffusion heterogeneity (β) were calculated for whole‐tumor volume. Associations between histogram metrics and prognostic factors (estrogen receptor [ER], progesterone receptor [PR], human epidermal growth factor receptor 2 [HER2], and Ki‐67 proliferation index), axillary lymph node metastasis (ALNM), and tumor grade were assessed. The performance of histogram metrics, both alone and in combination, for differentiating molecular subtypes (HER2‐positive, Luminal or triple negative) was also assessed.Statistical Tests: Comparisons were made using Mann–Whitney test between different prognostic factor statuses and molecular subtypes. Receiver operating characteristic curve analysis was used to assess the performance of mean and median histogram metrics in differentiating the molecular subtypes. A P value D, and α differed significantly between ER‐positive and ER‐negative status, and between PR‐positive and PR‐negative status. The histogram metrics of ADC, D, α, and β were also significantly different between the HER2‐positive and HER2‐negative subgroups, and between ALNM‐positive and ALNM‐negative subgroups. The histogram metrics of α and β significantly differed between high and low Ki‐67 proliferation subgroups, and between histological grade subgroups. The combination of αmean and βmean achieved the highest performance (AUC = 0.702) to discriminate the Luminal and HER2‐positive subtypes.Data Conclusion: Whole‐tumor histogram analysis of the CTRW model has potential to provide additional information on the prognosis and intrinsic subtyping classification of breast cancer.Evidence Level: 4Technical Efficacy: Stage 2
- 17 October 2022
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 58 (1) , 93-105
Assessment of Prognostic Factors and Molecular Subtypes of Breast Cancer With a Continuous‐Time Random‐Walk MR Diffusion Model: Using Whole Tumor Histogram Analysis
Background: The continuous‐time random‐walk (CTRW) diffusion model to evaluate breast cancer prognosis is rarely reported.Purpose: To investigate the correlations between apparent diffusion coefficient (ADC) and CTRW‐specific parameters with prognostic factors and molecular subtypes of breast cancer.Study Type: Retrospective.Population: One hundred fifty‐seven women (median age, 50 years; range, 26–81 years) with histopathology‐confirmed breast cancer.Field Strength/Sequence: Simultaneous multi‐slice readout‐segmented echo‐planar imaging at 3.0T.Assessment: The histogram metrics of ADC, anomalous diffusion coefficient (D), temporal diffusion heterogeneity (α), and spatial diffusion heterogeneity (β) were calculated for whole‐tumor volume. Associations between histogram metrics and prognostic factors (estrogen receptor [ER], progesterone receptor [PR], human epidermal growth factor receptor 2 [HER2], and Ki‐67 proliferation index), axillary lymph node metastasis (ALNM), and tumor grade were assessed. The performance of histogram metrics, both alone and in combination, for differentiating molecular subtypes (HER2‐positive, Luminal or triple negative) was also assessed.Statistical Tests: Comparisons were made using Mann–Whitney test between different prognostic factor statuses and molecular subtypes. Receiver operating characteristic curve analysis was used to assess the performance of mean and median histogram metrics in differentiating the molecular subtypes. A P value D, and α differed significantly between ER‐positive and ER‐negative status, and between PR‐positive and PR‐negative status. The histogram metrics of ADC, D, α, and β were also significantly different between the HER2‐positive and HER2‐negative subgroups, and between ALNM‐positive and ALNM‐negative subgroups. The histogram metrics of α and β significantly differed between high and low Ki‐67 proliferation subgroups, and between histological grade subgroups. The combination of αmean and βmean achieved the highest performance (AUC = 0.702) to discriminate the Luminal and HER2‐positive subtypes.Data Conclusion: Whole‐tumor histogram analysis of the CTRW model has potential to provide additional information on the prognosis and intrinsic subtyping classification of breast cancer.Evidence Level: 4Technical Efficacy: Stage 2